295 related articles for article (PubMed ID: 22560714)
21. Dose escalation in the radiotherapy of non-small-cell lung cancer with aperture-based intensity modulation and photon beam energy optimization for non-preselected patients.
St-Hilaire J; Sévigny C; Beaulieu F; Germain F; Lavoie C; Dagnault A; Gingras L; Tremblay D; Beaulieu L
Radiother Oncol; 2009 Jun; 91(3):342-8. PubMed ID: 19135749
[TBL] [Abstract][Full Text] [Related]
22. Dosimetric advantages of IMPT over IMRT for laser-accelerated proton beams.
Luo W; Li J; Fourkal E; Fan J; Xu X; Chen Z; Jin L; Price R; Ma CM
Phys Med Biol; 2008 Dec; 53(24):7151-66. PubMed ID: 19033641
[TBL] [Abstract][Full Text] [Related]
23. Spot-Scanning Proton Arc (SPArc) Therapy: The First Robust and Delivery-Efficient Spot-Scanning Proton Arc Therapy.
Ding X; Li X; Zhang JM; Kabolizadeh P; Stevens C; Yan D
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1107-1116. PubMed ID: 27869083
[TBL] [Abstract][Full Text] [Related]
24. Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer.
Huang Q; Jabbour SK; Xiao Z; Yue N; Wang X; Cao H; Kuang Y; Zhang Y; Nie K
Radiat Oncol; 2018 Apr; 13(1):78. PubMed ID: 29695284
[TBL] [Abstract][Full Text] [Related]
25. Technical Note: 4D robust optimization in small spot intensity-modulated proton therapy (IMPT) for distal esophageal carcinoma.
Feng H; Shan J; Ashman JB; Rule WG; Bhangoo RS; Yu NY; Chiang J; Fatyga M; Wong WW; Schild SE; Sio TT; Liu W
Med Phys; 2021 Aug; 48(8):4636-4647. PubMed ID: 34058026
[TBL] [Abstract][Full Text] [Related]
26. Energy layer optimization strategies for intensity-modulated proton therapy of lung cancer patients.
Jensen MF; Hoffmann L; Petersen JBB; Møller DS; Alber M
Med Phys; 2018 Oct; 45(10):4355-4363. PubMed ID: 30129041
[TBL] [Abstract][Full Text] [Related]
27. Clinical application of a novel hybrid intensity-modulated radiotherapy technique for stage III lung cancer and dosimetric comparison with four other techniques.
Verbakel WF; van Reij E; Ladenius-Lischer I; Cuijpers JP; Slotman BJ; Senan S
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e297-303. PubMed ID: 22579380
[TBL] [Abstract][Full Text] [Related]
28. A treatment planning study of the potential of geometrical tracking for intensity modulated proton therapy of lung cancer.
Munck af Rosenschöld P; Aznar MC; Nygaard DE; Persson GF; Korreman SS; Engelholm SA; Nyström H
Acta Oncol; 2010 Oct; 49(7):1141-8. PubMed ID: 20831506
[TBL] [Abstract][Full Text] [Related]
29. Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer.
Vogelius IR; Westerly DC; Aznar MC; Cannon GM; Korreman SS; Mackie TR; Mehta MP; Bentzen SM
Acta Oncol; 2011 Aug; 50(6):772-6. PubMed ID: 21767173
[TBL] [Abstract][Full Text] [Related]
30. Comparison of dose-volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer.
Ohno T; Oshiro Y; Mizumoto M; Numajiri H; Ishikawa H; Okumura T; Terunuma T; Sakae T; Sakurai H
J Radiat Res; 2015 Jan; 56(1):128-33. PubMed ID: 25368341
[TBL] [Abstract][Full Text] [Related]
31. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
[TBL] [Abstract][Full Text] [Related]
32. A dosimetric comparison of intensity-modulated proton therapy optimization techniques for pediatric craniopharyngiomas: a clinical case study.
Yeung D; McKenzie C; Indelicato DJ
Pediatr Blood Cancer; 2014 Jan; 61(1):89-94. PubMed ID: 24000229
[TBL] [Abstract][Full Text] [Related]
33. Potential for radiation therapy technology innovations to permit dose escalation for non-small-cell lung cancer.
Manon RR; Jaradat H; Patel R; Zhang T; Fenwick J; Tome W; Fowler J; Paliwal B; Soisson E; Yuan Z; Mehta M
Clin Lung Cancer; 2005 Sep; 7(2):107-13. PubMed ID: 16179097
[TBL] [Abstract][Full Text] [Related]
34. Evaluation and mitigation of the interplay effects of intensity modulated proton therapy for lung cancer in a clinical setting.
Kardar L; Li Y; Li X; Li H; Cao W; Chang JY; Liao L; Zhu RX; Sahoo N; Gillin M; Liao Z; Komaki R; Cox JD; Lim G; Zhang X
Pract Radiat Oncol; 2014; 4(6):e259-68. PubMed ID: 25407877
[TBL] [Abstract][Full Text] [Related]
35. Uncertainty reduction in intensity modulated proton therapy by inverse Monte Carlo treatment planning.
Morávek Z; Rickhey M; Hartmann M; Bogner L
Phys Med Biol; 2009 Aug; 54(15):4803-19. PubMed ID: 19622848
[TBL] [Abstract][Full Text] [Related]
36. Impact of intensity-modulated radiation therapy as a boost treatment on the lung-dose distributions for non-small-cell lung cancer.
Choi Y; Kim JK; Lee HS; Hur WJ; Chai GY; Kang KM
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):683-9. PubMed ID: 15927412
[TBL] [Abstract][Full Text] [Related]
37. Assessment of robustness against setup uncertainties using probabilistic scenarios in lung cancer: a comparison of proton with photon therapy.
Teoh S; George B; Fiorini F; Vallis KA; Van den Heuvel F
Br J Radiol; 2020 Mar; 93(1107):20190584. PubMed ID: 31977241
[TBL] [Abstract][Full Text] [Related]
38. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
[TBL] [Abstract][Full Text] [Related]
39. Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study.
Nichols RC; Huh SN; Henderson RH; Mendenhall NP; Flampouri S; Li Z; D'Agostino HJ; Cury JD; Pham DC; Hoppe BS
Clin Lung Cancer; 2011 Jul; 12(4):252-7. PubMed ID: 21726825
[TBL] [Abstract][Full Text] [Related]
40. Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy.
Chi A; Lin LC; Wen S; Yan H; Hsi WC
Radiat Oncol; 2017 Aug; 12(1):132. PubMed ID: 28810881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]